Novartis influenza A H1N1 vaccine clinical data

Although the influenza 2009 H1N1 vaccine produced by Novartis, Fluvirin, was previously approved for use in the US, the clinical data supporting its safety and immunogenicity had not been released. The company has now issued a media release containing interim clinical data on the effects of the vaccine in humans. According to the company, testing …

Novartis influenza A H1N1 vaccine clinical data Read More »